Novavax Begins Shipping Covid Vaccine to Europe

The transcript discusses Novak's COVID-19 vaccine shipments to Europe and other countries, highlighting the company's milestone. It covers the vaccine's efficacy, Covax commitment, and regulatory updates in Canada and the US. The potential for a combination flu-COVID vaccine is explored, along with other vaccine developments like RSV and malaria. The response to the Omicron variant is also addressed, with ongoing trials and production efforts.

What are the expected characteristics of the vaccine that aid in its distribution?

What is the company's plan regarding a combination vaccine for COVID-19 and flu?

What updates were provided regarding the FDA approval process for the vaccine?